Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alpha-interferon and mental disorders].

C Debien1, M B De Chouly De Lenclave, P Foutrein

  • 1Service de Psychiatrie Adulte, CHRU de Lille, 6, rue du Professeur Laguesse, 59037 Lille.

L'Encephale
|November 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 3114: A new professional helpline to swing the French suicide prevention in a new paradigm.

European psychiatry : the journal of the Association of European Psychiatrists·2022
Same author

Effectiveness of a French Program to Prevent Suicide Reattempt (VigilanS).

Archives of suicide research : official journal of the International Academy for Suicide Research·2020
Same author

[An example of post-discharge monitoring after a suicide attempt: VigilanS].

L'Encephale·2018
Same author

[Changes in the number of suicide attempts in the NPC region since the start of VigilanS: First estimates].

L'Encephale·2018
Same author

["VigilanSeu.r.se": A new profession?]

L'Encephale·2018
Same author

[First trends of change in mortality by suicide in Nord-Pas-de-Calais since VigilanS].

L'Encephale·2018
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Interferon alpha therapy can cause significant neuropsychiatric side effects, including depression and psychosis, in up to 30% of patients. Management involves careful monitoring and specific psychiatric interventions to mitigate these risks.

Area of Science:

  • Oncology
  • Virology
  • Neuropsychiatry

Context:

  • Interferon alpha is a key treatment in oncology and virology.
  • Neuropsychiatric side effects frequently limit its efficacy.
  • Psychiatric complications are a major cause for treatment reduction or cessation.

Purpose:

  • To review and discuss the link between interferon therapy and psychiatric disorders.
  • To explore the mechanisms of interferon-induced toxicity.
  • To synthesize practical management strategies for these complications.

Summary:

  • Interferon alpha can induce a range of psychiatric disorders, including depression, anxiety, mood disorders, and psychotic symptoms, in up to 30% of patients.
  • These effects appear dose-dependent and can manifest early or later in treatment.

Related Experiment Videos

  • While direct causality is difficult to establish definitively, evidence suggests a strong link between interferon and neuropsychiatric complications.

    • Impact:

    • Highlights the significant psychiatric morbidity associated with interferon therapy.
    • Underscores the need for proactive psychiatric monitoring and management.
    • Emphasizes the importance of further research into toxicity mechanisms and optimized patient care.